709 filings
Page 3 of 36
8-K
j1crvln
27 Dec 23
Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration
7:48am
424B5
7k5r24p6i1wzebpjcl8
21 Nov 23
Prospectus supplement for primary offering
7:40pm
8-K
m0r4a1tixbu6zigwe
20 Nov 23
Zevra Therapeutics Completes Acquisition of Acer Therapeutics in its Journey to Become a Leading Rare Disease Company
7:36am
8-K
j9gmi7 wywgy6yv
7 Nov 23
Zevra Therapeutics Reports Corporate Updates and Third Quarter 2023 Financial
7:25am
425
jsn1byhgf40st98pumam
30 Oct 23
Business combination disclosure
4:42pm
8-K
b4ruvplz
30 Oct 23
Other Events
8:25am
4
p98uad3kvjufn6yx
11 Oct 23
ZEVRA THERAPEUTICS / Neil F. McFarlane ownership change
4:33pm
EFFECT
6eksew fq8fixqsuh
11 Oct 23
Notice of effectiveness
12:15am
3
751ljozb5vtn5bvy
10 Oct 23
ZEVRA THERAPEUTICS / Neil F. McFarlane ownership change
8:20pm
8-K
xkydfaoqeytygyvx5u
10 Oct 23
Departure of Directors or Certain Officers
5:12pm
424B3
iz5euwqro4gbndf
10 Oct 23
Prospectus supplement
5:07pm
S-4/A
02gfkepie ofzvd
6 Oct 23
Registration of securities issued in business combination transactions (amended)
4:06pm
CORRESP
e4v1wn5gz z6jr46
6 Oct 23
Correspondence with SEC
12:00am
UPLOAD
h67h6iw4q
4 Oct 23
Letter from SEC
12:00am
S-4
ojt4ibhr
28 Sep 23
Registration of securities issued in business combination transactions
9:25pm
4
p9ksb7v9523f2z0q5z
6 Sep 23
ZEVRA THERAPEUTICS / Joshua Schafer ownership change
5:11pm
4
hvpw58g8siardamxewwx
6 Sep 23
ZEVRA THERAPEUTICS / R. LaDuane Clifton ownership change
5:11pm
4
xpyxh
6 Sep 23
ZEVRA THERAPEUTICS / John B Bode ownership change
4:40pm
4
walqrz1wu1
6 Sep 23
ZEVRA THERAPEUTICS / Thomas Anderson ownership change
4:39pm